Login

Unveiling the Motivations behind Evolis' Intended Sale to HID Group | Emmanuel Picot, CEO of Evolis sa 00:10:00

Share On Facebook Share On Twitter

Emmanuel Picot is Chairman/CEO at Evolis SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Positive Trends in China Internet Sector: Travel, E-Commerce, and Cloud Computing
00:10:00
Adam Melnick on Capital Resources' Strategic Growth in Copper Exploration
00:10:00
Bonds, Technology, and Global Markets: An In-Depth Discussion with PGIM CEO David Hunt | David Hunt, CEO , PGIM.
00:10:00
From Medical Aspirations to Global Leadership at KPMG | William B. Thomas, CEO , KPMG.
00:10:00
Sandstorm Gold focuses on debt reduction and pending production growth from key assets while anticipating sector upside amidst stable cash flow leverage to gold price.|Nolan Watson Ceo Of Sandstorm Gold Royalties
00:10:00
Q4 2023 Market Recap & 2024 Outlook | Jason Gunkel - Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
Debut Capital helps their founders in product, tech stack strategy|Pilar Johnson,Co-Founder and Managing Partner,Debut Capital
00:00:00
Pam Silver | Addressing Global Issues Through Biology
00:10:00
Base Resources Overview: Operations, Projects, and Financials
00:10:00
MINTO Apartment REIT Rings Opening Bell at Toronto Stock Exchange
00:10:00
GE Hitachi Nuclear Energy, BWXT Canada, and Synthos Green Energy collaborate to deploy BWRX-300 small modular reactors in Poland, advancing nuclear energy initiatives.|Rex D. Geveden is president and chief executive officer of BWX Technologies, Inc. (BWXT
00:10:00
Nordea's Robust Performance and Strategic Outlook Amid Global Challenges | Frank Vang-Jensen, CEO, Nordea .

© 2017 - Neuhu+